PUBLISHER: The Business Research Company | PRODUCT CODE: 1947074
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947074
Respiratory oxygen delivery devices are medical tools crafted to administer oxygen to patients requiring supplemental oxygen therapy to support their breathing. They are employed to provide oxygen therapy to individuals with respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, other lung diseases, as well as those experiencing hypoxemia due to various medical conditions or environmental factors.
The primary product types of respiratory oxygen delivery devices include oxygen masks, nasal cannulas, ventilator masks, non-rebreather masks, bag valve masks, continuous positive airway pressure (CPAP) masks, among others. Oxygen masks are designed to deliver oxygen to patients by covering the nose and mouth, facilitating the inhalation of oxygen-enriched air. These devices are utilized across applications such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, respiratory distress syndrome, pneumonia, among others, and are utilized by end-users including hospitals, outpatient facilities, and home care settings.
Tariffs are impacting the respiratory oxygen delivery devices market by increasing costs of imported medical-grade plastics, flow regulators, sensors, valves, and electronic monitoring components used in oxygen masks, cannulas, and concentrators. Hospitals and homecare providers in North America and Europe are most affected due to reliance on globally sourced components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising device procurement costs and impacting affordability in price-sensitive markets. However, they are also encouraging local manufacturing, regional sourcing of medical components, and investments in cost-optimized oxygen delivery solutions.
The respiratory oxygen delivery devices market research report is one of a series of new reports from The Business Research Company that provides respiratory oxygen delivery devices market statistics, including respiratory oxygen delivery devices industry global market size, regional shares, competitors with a respiratory oxygen delivery devices market share, detailed respiratory oxygen delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory oxygen delivery devices industry. This respiratory oxygen delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory oxygen delivery devices market size has grown rapidly in recent years. It will grow from $16.53 billion in 2025 to $18.26 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising prevalence of chronic respiratory diseases, increased hospital admissions for respiratory conditions, expansion of critical care infrastructure, growing aging population with oxygen dependency, wider availability of medical oxygen delivery solutions.
The respiratory oxygen delivery devices market size is expected to see strong growth in the next few years. It will grow to $25.69 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for home healthcare services, growing focus on early respiratory disease management, expansion of smart connected medical devices, increasing investments in respiratory care technologies. Major trends in the forecast period include increasing adoption of high-flow oxygen delivery systems, rising demand for home-based oxygen therapy devices, growing integration of smart oxygen monitoring features, expansion of portable and lightweight oxygen devices, enhanced focus on patient comfort and compliance.
The rising prevalence of asthma is expected to drive the growth of the respiratory oxygen delivery device market moving forward. Asthma is a chronic respiratory condition marked by airway inflammation and constriction, causing recurring episodes of wheezing, coughing, chest tightness, and shortness of breath. The incidence of asthma is increasing due to factors such as air pollution, allergen exposure, genetic predisposition, lifestyle and dietary changes, and urbanization. Respiratory oxygen delivery devices assist in asthma management by providing supplemental oxygen during exacerbations, ensuring sufficient oxygenation, alleviating symptoms, and improving overall respiratory function and quality of life. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, there were 474 asthma-related deaths in Australia in 2023, including 325 females and 149 males, nearly matching the 473 deaths reported in 2022. Therefore, the rising prevalence of asthma is driving the respiratory oxygen delivery devices market.
Major companies in the respiratory oxygen delivery device market are focusing on integrating advanced sensor control systems and connectivity features to enhance patient monitoring and therapy effectiveness. These technologies enable devices to automatically adjust performance based on sensor feedback while providing remote access, data sharing, and real-time communication through wireless or network connections. For instance, in October 2024, Inogen, Inc., a US-based medical device company, launched the Rove 4 portable oxygen concentrator, featuring Bluetooth connectivity via the Inogen Connect app. The app allows users to remotely monitor oxygen purity, battery life, and flow settings from their smartphones, illustrating the industry's move toward connected, high-efficiency PSA-based oxygen devices that support real-time tracking and smarter home therapy.
In February 2023, React Health Inc., a US-based manufacturer and distributor of medical devices for sleep-disordered breathing and oxygen therapy, completed the acquisition of a respiratory product line from Invacare Holdings Corporation for an undisclosed sum. This acquisition broadens React Health's product portfolio to encompass essential respiratory devices, strengthening its foothold in the medical device market, particularly in sleep-disordered breathing and oxygen therapy treatments. Invacare Holdings Corporation is a US-based manufacturing company specializing in respiratory therapy medical equipment, including stationary oxygen concentrators and oxygen refilling devices.
Major companies operating in the respiratory oxygen delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group, Teleflex Incorporated, Masimo Corporation, Chart Industries Inc., Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hamilton Medical AG, GaleMed Corporation, Weinmann Emergency Medical Technology GmbH And Co. KG, Precision Medical Inc., Allied Healthcare Products Inc., Salter Labs Inc.
Asia-Pacific was the largest region in the respiratory oxygen delivery devices market in 2025. The regions covered in the respiratory oxygen delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the respiratory oxygen delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The respiratory oxygen delivery devices market consists of sales of nasal cannulas, oxygen masks, oxygen concentrators, and oxygen cylinders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Oxygen Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses respiratory oxygen delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory oxygen delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory oxygen delivery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.